Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 529

1.

Variable carbon and chlorine isotope fractionation in TCE co-metabolic oxidation.

Gafni A, Gelman F, Ronen Z, Bernstein A.

Chemosphere. 2019 Oct 18;242:125130. doi: 10.1016/j.chemosphere.2019.125130. [Epub ahead of print]

PMID:
31669996
2.

The British Columbia Healthy Connections Project: findings on socioeconomic disadvantage in early pregnancy.

Catherine NLA, Lever R, Sheehan D, Zheng Y, Boyle MH, McCandless L, Gafni A, Gonzalez A, Jack SM, Tonmyr L, Varcoe C, MacMillan HL, Waddell C; British Columbia Healthy Connections Project Scientific Team.

BMC Public Health. 2019 Aug 22;19(1):1161. doi: 10.1186/s12889-019-7479-5.

3.

Insights on multimorbidity and associated health service use and costs from three population-based studies of older adults in Ontario with diabetes, dementia and stroke.

Griffith LE, Gruneir A, Fisher K, Panjwani D, Gafni A, Patterson C, Markle-Reid M, Ploeg J.

BMC Health Serv Res. 2019 May 16;19(1):313. doi: 10.1186/s12913-019-4149-3.

4.

Reporting quality of pilot clinical trials in chronic kidney disease patients on hemodialysis: a methodological survey.

Kosa SD, Monize J, Leenus A, Leenus S, Samra S, Szwiega S, Shi D, Valvasori S, Gafni A, Lok CE, Thabane L.

Pilot Feasibility Stud. 2019 Apr 6;5:53. doi: 10.1186/s40814-019-0436-3. eCollection 2019.

5.

Nutritional Mobile Applications for CKD Patients: Systematic Review.

Kosa SD, Monize J, D'Souza M, Joshi A, Philip K, Reza S, Samra S, Serrago B, Thabane L, Gafni A, Lok CE.

Kidney Int Rep. 2018 Nov 29;4(3):399-407. doi: 10.1016/j.ekir.2018.11.016. eCollection 2019 Mar.

6.

Authors' reply re: Urinary stress incontinence and other maternal outcomes 2 years after caesarean or vaginal birth for twin pregnancy: a multicentre randomised trial.

Hutton EK, Hannah ME, Willan A, Ross S, Armson A, Gafni A, Joseph KS, Mangoff K, Ohlsson A, Sanchez J, Asztalos E, Barrett J; Twin Birth Study Collaborative Group.

BJOG. 2019 Mar;126(4):547. doi: 10.1111/1471-0528.15582. No abstract available.

PMID:
30729657
7.

The cost implication of primary prevention in the HOPE 3 trial.

Lamy A, Lonn E, Tong W, Swaminathan B, Jung H, Gafni A, Bosch J, Yusuf S.

Eur Heart J Qual Care Clin Outcomes. 2019 Jul 1;5(3):266-271. doi: 10.1093/ehjqcco/qcz001.

PMID:
30657891
8.

CHIPS-Child: Testing the developmental programming hypothesis in the offspring of the CHIPS trial.

Magee LA, Synnes AR, von Dadelszen P, Hutfield AM, Chanoine JP, Côté AM, Devlin AM, Dorling J, Gafni A, Ganzevoort W, Helewa ME, Hutton EK, Koren G, Lee SK, Mcarthur D, Rey E, Robinson WP, Roseboom TJ, Singer J, Wilson S, Moutquin JM; CHIPS-Child Study Group (Table S1).

Pregnancy Hypertens. 2018 Oct;14:15-22. doi: 10.1016/j.preghy.2018.04.021. Epub 2018 May 19.

9.

Measuring Public Preferences for Health Outcomes and Expenditures in a Context of Healthcare Resource Re-Allocation.

Krucien N, Pelletier-Fleury N, Gafni A.

Pharmacoeconomics. 2019 Mar;37(3):407-417. doi: 10.1007/s40273-018-0751-1.

PMID:
30499065
10.

Postoperative complications in elderly patients following pancreaticoduodenectomy lead to increased postoperative mortality and costs. A retrospective cohort study.

Yuan F, Essaji Y, Belley-Cote EP, Gafni A, Latchupatula L, Ruo L, Serrano PE.

Int J Surg. 2018 Dec;60:204-209. doi: 10.1016/j.ijsu.2018.11.016. Epub 2018 Nov 20.

PMID:
30468904
11.

The evolution of GRADE (part 3): A framework built on science or faith?

Mercuri M, Gafni A.

J Eval Clin Pract. 2018 Oct;24(5):1223-1231. doi: 10.1111/jep.13016. Epub 2018 Jul 31.

PMID:
30066429
12.

The evolution of GRADE (part 2): Still searching for a theoretical and/or empirical basis for the GRADE framework.

Mercuri M, Gafni A.

J Eval Clin Pract. 2018 Oct;24(5):1211-1222. doi: 10.1111/jep.12997. Epub 2018 Jul 17.

PMID:
30015389
13.

The evolution of GRADE (part 1): Is there a theoretical and/or empirical basis for the GRADE framework?

Mercuri M, Gafni A.

J Eval Clin Pract. 2018 Oct;24(5):1203-1210. doi: 10.1111/jep.12998. Epub 2018 Jul 16.

PMID:
30009394
14.

Urinary stress incontinence and other maternal outcomes 2 years after caesarean or vaginal birth for twin pregnancy: a multicentre randomised trial.

Hutton EK, Hannah ME, Willan AR, Ross S, Allen AC, Armson BA, Gafni A, Joseph KS, Mangoff K, Ohlsson A, Sanchez JJ, Asztalos EV, Barrett J; Twin Birth Study Collaborative Group.

BJOG. 2018 Dec;125(13):1682-1690. doi: 10.1111/1471-0528.15407. Epub 2018 Aug 27.

15.

A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer.

Sawka AM, Ghai S, Tomlinson G, Rotstein L, Gilbert R, Gullane P, Pasternak J, Brown D, de Almeida J, Irish J, Chepeha D, Higgins K, Monteiro E, Jones JM, Gafni A, Goldstein DP.

BMJ Open. 2018 Apr 12;8(4):e020298. doi: 10.1136/bmjopen-2017-020298.

16.

Interactions of amyloid-β peptides on lipid bilayer studied by single molecule imaging and tracking.

Chang CC, Edwald E, Veatch S, Steel DG, Gafni A.

Biochim Biophys Acta Biomembr. 2018 Mar 24. pii: S0005-2736(18)30097-X. doi: 10.1016/j.bbamem.2018.03.017. [Epub ahead of print]

17.

Community Program Improves Quality of Life and Self-Management in Older Adults with Diabetes Mellitus and Comorbidity.

Markle-Reid M, Ploeg J, Fraser KD, Fisher KA, Bartholomew A, Griffith LE, Miklavcic J, Gafni A, Thabane L, Upshur R.

J Am Geriatr Soc. 2018 Feb;66(2):263-273. doi: 10.1111/jgs.15173. Epub 2017 Nov 27.

18.

Hemodialysis Infection Prevention Protocols Ontario-Shower Technique (HIPPO-ST): A Pilot Randomized Trial.

Kosa SD, Gafni A, House AA, Lawrence J, Moist L, Nathoo B, Tam P, Sarabia A, Thabane L, Wu G, Lok CE.

Kidney Int Rep. 2016 Nov 8;2(2):228-238. doi: 10.1016/j.ekir.2016.11.001. eCollection 2017 Mar.

19.

Predicting tissue plasminogen activator use and success in in-center hemodialysis patients.

Kosa SD, Ye C, Thabane L, Gafni A, Lok CE.

J Vasc Access. 2018 Mar;19(2):146-152. doi: 10.5301/jva.5000785. Epub 2018 Feb 19.

PMID:
28983900
20.

Examining the role of the physician as a source of variation: Are physician-related variations necessarily unwarranted?

Mercuri M, Gafni A.

J Eval Clin Pract. 2018 Feb;24(1):145-151. doi: 10.1111/jep.12770. Epub 2017 May 29. Review.

PMID:
28556526
21.

The TRIO Framework: Conceptual insights into family caregiver involvement and influence throughout cancer treatment decision-making.

Laidsaar-Powell R, Butow P, Charles C, Gafni A, Entwistle V, Epstein R, Juraskova I.

Patient Educ Couns. 2017 Nov;100(11):2035-2046. doi: 10.1016/j.pec.2017.05.014. Epub 2017 May 5. Review.

PMID:
28552193
22.

Attributing a monetary value to patients' time: A contingent valuation approach.

van den Berg B, Gafni A, Portrait F.

Soc Sci Med. 2017 Apr;179:182-190. doi: 10.1016/j.socscimed.2017.02.025. Epub 2017 Feb 20.

PMID:
28288314
23.

The ACHRU-CPP versus usual care for older adults with type-2 diabetes and multiple chronic conditions and their family caregivers: study protocol for a randomized controlled trial.

Markle-Reid M, Ploeg J, Fraser KD, Fisher KA, Akhtar-Danesh N, Bartholomew A, Gafni A, Gruneir A, Hirst SP, Kaasalainen S, Stradiotto CK, Miklavcic J, Rojas-Fernandez C, Sadowski CA, Thabane L, Triscott JA, Upshur R.

Trials. 2017 Feb 6;18(1):55. doi: 10.1186/s13063-017-1795-9.

24.

The Aging, Community and Health Research Unit-Community Partnership Program for older adults with type 2 diabetes and multiple chronic conditions: a feasibility study.

Markle-Reid M, Ploeg J, Fisher K, Reimer H, Kaasalainen S, Gafni A, Gruneir A, Kirkconnell R, Marzouk S, Akhtar-Danesh N, Thabane L, Rojas-Fernandez C, Upshur R.

Pilot Feasibility Stud. 2016 May 9;2:24. eCollection 2016.

25.

Comorbidity and its relationship with health service use and cost in community-living older adults with diabetes: A population-based study in Ontario, Canada.

Fisher K, Griffith L, Gruneir A, Panjwani D, Gandhi S, Sheng LL, Gafni A, Chris P, Markle-Reid M, Ploeg J.

Diabetes Res Clin Pract. 2016 Dec;122:113-123. doi: 10.1016/j.diabres.2016.10.009. Epub 2016 Oct 20.

PMID:
27833049
26.

Patterns of health service use in community living older adults with dementia and comorbid conditions: a population-based retrospective cohort study in Ontario, Canada.

Griffith LE, Gruneir A, Fisher K, Panjwani D, Gandhi S, Sheng L, Gafni A, Patterson C, Markle-Reid M, Ploeg J.

BMC Geriatr. 2016 Oct 26;16(1):177.

27.

Increasing comorbidity and health services utilization in older adults with prior stroke.

Gruneir A, Griffith LE, Fisher K, Panjwani D, Gandhi S, Sheng L, Patterson C, Gafni A, Ploeg J, Markle-Reid M.

Neurology. 2016 Nov 15;87(20):2091-2098. Epub 2016 Oct 19.

28.

Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study).

Vidler M, Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM; CHIPS Study Group.

Eur J Obstet Gynecol Reprod Biol. 2016 Nov;206:105-113. doi: 10.1016/j.ejogrb.2016.07.509. Epub 2016 Sep 10.

29.

The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?

Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM; CHIPS Study Group*.

Hypertension. 2016 Nov;68(5):1153-1159. Epub 2016 Sep 12.

30.

The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial).

Ahmed RJ, Gafni A, Hutton EK, Hu ZJ, Pullenayegum E, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez JJ, Ganzevoort W, Helewa M, Lee SK, Lee T, Logan AG, Moutquin JM, Singer J, Thornton JG, Welch R, Magee LA.

Hypertension. 2016 Oct;68(4):1049-55. doi: 10.1161/HYPERTENSIONAHA.116.07466. Epub 2016 Aug 22.

31.

Challenges in striving to simultaneously achieve multiple resource allocation goals: the pan-Canadian Oncology Drug Review (pCODR) example.

McDonald H, Charles C, Elit L, Gafni A.

J Mark Access Health Policy. 2016 Jul 21;4. doi: 10.3402/jmahp.v4.31463. eCollection 2016.

32.

Positron Emission Tomography-Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial.

Serrano PE, Gafni A, Gu CS, Gulenchyn KY, Julian JA, Law C, Hendler AL, Moulton CA, Gallinger S, Levine MN.

J Oncol Pract. 2016 Jul;12(7):e765-74. doi: 10.1200/JOP.2016.011676. Epub 2016 Jun 21.

PMID:
27328792
33.

Designing, Implementing, and Evaluating Mobile Health Technologies for Managing Chronic Conditions in Older Adults: A Scoping Review.

Matthew-Maich N, Harris L, Ploeg J, Markle-Reid M, Valaitis R, Ibrahim S, Gafni A, Isaacs S.

JMIR Mhealth Uhealth. 2016 Jun 9;4(2):e29. doi: 10.2196/mhealth.5127. Review.

34.

A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells.

Volovitz I, Shapira N, Ezer H, Gafni A, Lustgarten M, Alter T, Ben-Horin I, Barzilai O, Shahar T, Kanner A, Fried I, Veshchev I, Grossman R, Ram Z.

BMC Neurosci. 2016 Jun 1;17(1):30. doi: 10.1186/s12868-016-0262-y.

35.

A review of health literacy: Definitions, interpretations, and implications for policy initiatives.

Malloy-Weir LJ, Charles C, Gafni A, Entwistle V.

J Public Health Policy. 2016 Aug;37(3):334-352. doi: 10.1057/jphp.2016.18. Epub 2016 May 19.

PMID:
27193502
36.

The Cost Implications in Ontario, Alberta, and British Columbia of Early Versus Delayed External Cephalic Version in the Early External Cephalic Version 2 (EECV2) Trial.

Ahmed RJ, Gafni A, Hutton EK; Early ECV2 Trial Collaborative Group.

J Obstet Gynaecol Can. 2016 Mar;38(3):235-245.e3. doi: 10.1016/j.jogc.2015.12.019. Epub 2016 Mar 29.

PMID:
27106193
37.

Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial.

Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM.

Acta Obstet Gynecol Scand. 2016 Jul;95(7):763-76. doi: 10.1111/aogs.12877. Epub 2016 Apr 7.

38.

Re: Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trial: Counselling is difficult when outcomes are associated with mode of delivery and not the plan of mode of delivery.

Hutton EK, Hannah ME, Ross S, Joseph KS, Ohlsson A, Asztalos E, Willan AR, Allen AC, Armson BA, Gafni A, Mangoff K, Sanchez JJ, Barrett JF; Twin Birth Study Collaborative Group.

BJOG. 2016 Mar;123(4):644. doi: 10.1111/1471-0528.13769. No abstract available.

39.

Family involvement in cancer treatment decision-making: A qualitative study of patient, family, and clinician attitudes and experiences.

Laidsaar-Powell R, Butow P, Bu S, Charles C, Gafni A, Fisher A, Juraskova I.

Patient Educ Couns. 2016 Jul;99(7):1146-1155. doi: 10.1016/j.pec.2016.01.014. Epub 2016 Jan 28.

PMID:
26873544
40.

Twin Birth Study: 2-year neurodevelopmental follow-up of the randomized trial of planned cesarean or planned vaginal delivery for twin pregnancy.

Asztalos EV, Hannah ME, Hutton EK, Willan AR, Allen AC, Armson BA, Gafni A, Joseph KS, Ohlsson A, Ross S, Sanchez JJ, Mangoff K, Barrett JF.

Am J Obstet Gynecol. 2016 Mar;214(3):371.e1-371.e19. doi: 10.1016/j.ajog.2015.12.051. Epub 2016 Jan 29.

PMID:
26830380
41.

[Is morphine indicated in patients with cardiac asthma? Indications for negative effects from the use of morphine].

Flinsenberg TW, van der Leeuw J, Gafni A, van Oostrom AJ, van Wijk JP.

Ned Tijdschr Geneeskd. 2015;159:A9388. Review. Dutch.

PMID:
26629602
42.

A randomized controlled trial of an intervention for infants' behavioral sleep problems.

Hall WA, Hutton E, Brant RF, Collet JP, Gregg K, Saunders R, Ipsiroglu O, Gafni A, Triolet K, Tse L, Bhagat R, Wooldridge J.

BMC Pediatr. 2015 Nov 13;15:181. doi: 10.1186/s12887-015-0492-7.

43.
44.

Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.

Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, Wei L, Mony P, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear SA, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Kazmi K, Rahman O, Rosengren A, Monsef N, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Temizhan A, Dagenais G, Gafni A, Yusuf S; PURE study investigators.

Lancet. 2016 Jan 2;387(10013):61-9. doi: 10.1016/S0140-6736(15)00469-9. Epub 2015 Oct 20.

PMID:
26498706
45.

Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trial.

Hutton EK, Hannah ME, Ross S, Joseph KS, Ohlsson A, Asztalos EV, Willan AR, Allen AC, Armson BA, Gafni A, Mangoff K, Sanchez JJ, Barrett JF; Twin Birth Study Collaborative Group.

BJOG. 2015 Nov;122(12):1653-62. doi: 10.1111/1471-0528.13597. Epub 2015 Aug 20.

46.

Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.

Magee LA; CHIPS Study Group, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM.

BJOG. 2016 Jun;123(7):1143-51. doi: 10.1111/1471-0528.13569. Epub 2015 Aug 11.

47.

Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?

Magee LA; CHIPS Study Group, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM.

BJOG. 2016 Jun;123(7):1135-41. doi: 10.1111/1471-0528.13568. Epub 2015 Aug 11.

48.

Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial.

Sawka AM, Straus S, Rodin G, Heus L, Brierley JD, Tsang RW, Rotstein L, Ezzat S, Segal P, Gafni A, Thorpe KE, Goldstein DP.

Cancer. 2015 Oct 15;121(20):3717-26. doi: 10.1002/cncr.29548. Epub 2015 Jul 20.

49.

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension.

Sawka AM, Straus S, Rodin G, Thorpe KE, Ezzat S, Gafni A, Goldstein DP.

Trials. 2015 Jul 14;16:302. doi: 10.1186/s13063-015-0819-6.

50.

Exploring the relationship between patients' information preference style and knowledge acquisition process in a computerized patient decision aid randomized controlled trial.

Sawka AM, Straus S, Rodin G, Tsang RW, Brierley JD, Rotstein L, Segal P, Gafni A, Ezzat S, Goldstein DP.

BMC Med Inform Decis Mak. 2015 Jun 19;15:48. doi: 10.1186/s12911-015-0168-0.

Supplemental Content

Support Center